市場調查報告書

虛擬臨床試驗- 全球市場的展望(2019年∼2027年)

Virtual Clinical Trials - Global Market Outlook (2019 -2027)

出版商 Stratistics Market Research Consulting 商品編碼 956133
出版日期 內容資訊 英文 168 Pages
商品交期: 2-3個工作天內
價格
虛擬臨床試驗- 全球市場的展望(2019年∼2027年) Virtual Clinical Trials - Global Market Outlook (2019 -2027)
出版日期: 2020年08月01日內容資訊: 英文 168 Pages
簡介

全球虛擬臨床試驗的市場規模預計2019年∼2027年之間以3.9%的年複合成長率發展。 醫療保健的數位化高漲,患者的多樣性造成強化臨床試驗的資料收集的必要性,及遠程醫療的採用,是推動市場成長的主要要素。但,落的臨床試驗妨礙市場成長。

本報告提供虛擬臨床試驗市場調查,市場概要,市場成長要素及阻礙因素分析,各類型、各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 全球虛擬臨床試驗市場:各相關

  • 循環系統疾病
  • 腫瘤學

第6章 全球虛擬臨床試驗市場:各研究設計

  • 擴張存取試用
  • 介入實驗
  • 觀察實驗

第7章 全球虛擬臨床試驗市場: 各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和近東及非洲的其他中東的地區

第8章 主要發展

  • 契約,夥伴關係,合作,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第9章 企業簡介

  • Clinical Ink
  • Covance
  • CRF Health
  • ICON plc
  • LEO Innovation Lab
  • Medable
  • Medidata
  • Oracle
  • Parexel
  • PRA Health Sciences
  • Science 37
目錄

According to Stratistics MRC, the Global Virtual Clinical Trials Market is anticipated to grow at a CAGR of 3.9% during 2019-2027. Rising healthcare digitization, need for patient diversity clubbed with enhanced data collection in clinical trials, and adoption of tele health are the major factors propelling the market growth. However, outdated clinical trials are hampering the market growth.

Virtual clinical trials are a relatively new method of collecting safety and efficacy data from human trial participants. These trials take full advantage of the omnipresent technology and online social engagement that are a part of its participants' lives, by using electronic versions of all trial processes including recruitment, informed consent, patient counselling, and data collection.

Based on the study design, the interventional trials segment is going to have a lucrative growth during the forecast period due to the increasing number of studies to develop new medications for various diseases. Furthermore, the digitalization of various laboratories has fuelled the market growth for this segment.

By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the rising outsourced research and development activities in this region to deliver advanced healthcare. Furthermore, increasing per capita income and favorable government initiatives coupled with is boosting the market growth across the region.

Some of the key players profiled in the Virtual Clinical Trials Market include Clinical Ink, Covance, CRF Health, ICON plc, LEO Innovation Lab, Medable, Medidata, Oracle, Parexel, PRA Health Sciences, and Science 37.

Implications Covered:

  • Cardiovascular Disease
  • Oncology

Study Designs Covered:

  • Expanded Access Trials
  • Interventional Trials
  • Observational Trials

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019 2020, 2024, and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virtual Clinical Trials Market, By Implication

  • 5.1 Introduction
  • 5.2 Cardiovascular Disease
  • 5.3 Oncology

6 Global Virtual Clinical Trials Market, By Study Design

  • 6.1 Introduction
  • 6.2 Expanded Access Trials
  • 6.3 Interventional Trials
  • 6.4 Observational Trials

7 Global Virtual Clinical Trials Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Clinical Ink
  • 9.2 Covance
  • 9.3 CRF Health
  • 9.4 ICON plc
  • 9.5 LEO Innovation Lab
  • 9.6 Medable
  • 9.7 Medidata
  • 9.8 Oracle
  • 9.9 Parexel
  • 9.10 PRA Health Sciences
  • 9.11 Science 37

List of Tables

  • Table 1 Global Virtual Clinical Trials Market Outlook, By Region (2018-2027) ($MN)
  • Table 2 Global Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)
  • Table 3 Global Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)
  • Table 4 Global Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)
  • Table 5 Global Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)
  • Table 6 Global Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)
  • Table 7 Global Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)
  • Table 8 Global Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)
  • Table 9 North America Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)
  • Table 10 North America Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)
  • Table 11 North America Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)
  • Table 12 North America Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)
  • Table 13 North America Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)
  • Table 14 North America Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)
  • Table 15 North America Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)
  • Table 16 North America Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)
  • Table 17 Europe Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)
  • Table 18 Europe Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)
  • Table 19 Europe Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)
  • Table 20 Europe Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)
  • Table 21 Europe Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)
  • Table 22 Europe Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)
  • Table 23 Europe Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)
  • Table 24 Europe Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)
  • Table 25 Asia Pacific Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)
  • Table 26 Asia Pacific Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)
  • Table 27 Asia Pacific Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)
  • Table 28 Asia Pacific Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)
  • Table 29 Asia Pacific Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)
  • Table 30 Asia Pacific Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)
  • Table 31 Asia Pacific Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)
  • Table 32 Asia Pacific Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)
  • Table 33 South America Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)
  • Table 34 South America Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)
  • Table 35 South America Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)
  • Table 36 South America Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)
  • Table 37 South America Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)
  • Table 38 South America Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)
  • Table 39 South America Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)
  • Table 40 South America Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)
  • Table 41 Middle East & Africa Virtual Clinical Trials Market Outlook, By Country (2018-2027) ($MN)
  • Table 42 Middle East & Africa Virtual Clinical Trials Market Outlook, By Implication (2018-2027) ($MN)
  • Table 43 Middle East & Africa Virtual Clinical Trials Market Outlook, By Cardiovascular Disease (2018-2027) ($MN)
  • Table 44 Middle East & Africa Virtual Clinical Trials Market Outlook, By Oncology (2018-2027) ($MN)
  • Table 45 Middle East & Africa Virtual Clinical Trials Market Outlook, By Study Design (2018-2027) ($MN)
  • Table 46 Middle East & Africa Virtual Clinical Trials Market Outlook, By Expanded Access Trials (2018-2027) ($MN)
  • Table 47 Middle East & Africa Virtual Clinical Trials Market Outlook, By Interventional Trials (2018-2027) ($MN)
  • Table 48 Middle East & Africa Virtual Clinical Trials Market Outlook, By Observational Trials (2018-2027) ($MN)